138 related articles for article (PubMed ID: 37173657)
21. Estimating disability-adjusted life years for breast cancer and the impact of screening in female populations in China, 2015-2030: an exploratory prevalence-based analysis applying local weights.
Yan XX; Zhu J; Li YJ; Cao MD; Wang X; Wang H; Liu CC; Wang J; Li Y; Shi JF
Popul Health Metr; 2022 Oct; 20(1):19. PubMed ID: 36207752
[TBL] [Abstract][Full Text] [Related]
22. Trends in disability-adjusted life years of lung cancer among women from 2004 to 2030 in Guangzhou, China: A population-based study.
Lin X; Bloom MS; Du Z; Hao Y
Cancer Epidemiol; 2019 Dec; 63():101586. PubMed ID: 31522131
[TBL] [Abstract][Full Text] [Related]
23. [Burden of hepatitis B-associated diseases in China from 1990 to 2030].
Yao L; Lin S; Huang J; Wu Y
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Nov; 35(5):464-475. PubMed ID: 38148535
[TBL] [Abstract][Full Text] [Related]
24. The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study.
Li Y; Xu J; Gu Y; Sun X; Dong H; Chen C
JMIR Public Health Surveill; 2022 Mar; 8(3):e33191. PubMed ID: 34963658
[TBL] [Abstract][Full Text] [Related]
25. [Disease burden of breast cancer in women in China, 1990-2017].
Liu W; Wang LJ; Qi JL; Liu JM; You JL; Lin L; Yin P; Zhou MG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jul; 42(7):1225-1230. PubMed ID: 34814535
[No Abstract] [Full Text] [Related]
26. The burden of endometriosis in China from 1990 to 2019.
Wang Y; Wang X; Liao K; Luo B; Luo J
Front Endocrinol (Lausanne); 2022; 13():935931. PubMed ID: 36051388
[TBL] [Abstract][Full Text] [Related]
27. [Trends of burden on ischemic heart disease and epidemiological transition of related risk factors in China, 1990-2017].
Wang CR; Meng XF; Wang CP; Liu SW
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1703-1709. PubMed ID: 33297630
[No Abstract] [Full Text] [Related]
28. [Trend analysis and projection of cancer incidence in China between 1989 and 2008].
Chen WQ; Zheng RS; Zeng HM; Zhang SW; Zhao P; He J
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):517-24. PubMed ID: 22967471
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of mortality and years of life lost of malignant tumors among inhabitants in rural area of Feicheng city from 2000 to 2010].
Zhao LH; Wei WQ; Ma HM; Zhao DL
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):714-9. PubMed ID: 24332062
[TBL] [Abstract][Full Text] [Related]
30. The burden of oral cancer in China, 1990-2017: an analysis for the Global Burden of Disease, Injuries, and Risk Factors Study 2017.
Yang Y; Zhou M; Zeng X; Wang C
BMC Oral Health; 2021 Jan; 21(1):44. PubMed ID: 33509185
[TBL] [Abstract][Full Text] [Related]
31. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020.
Qiu H; Cao S; Xu R
Cancer Commun (Lond); 2021 Oct; 41(10):1037-1048. PubMed ID: 34288593
[TBL] [Abstract][Full Text] [Related]
32. [Burden of disease of colorectal cancer in the Chinese population, in 1990 and 2013].
Feng YJ; Wang N; Fang LW; Cong S; Yin P; Li YC; Zhou MG
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):768-72. PubMed ID: 27346099
[TBL] [Abstract][Full Text] [Related]
33. [Incidence and mortality of cancers appeared in the Hebei provincial cancer registry system in 2011].
He Y; Liang D; Li D; Zhai J; Liu B; Zhu J; Shan B
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Aug; 36(8):846-51. PubMed ID: 26714541
[TBL] [Abstract][Full Text] [Related]
34. [Cancer burden in the Jinchang cohort].
Bai Y; Qu H; Pu H; Dai M; Cheng N; Li H; Chang S; Li J; Kang F; Hu X; Ren X; He J
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):306-10. PubMed ID: 27005525
[TBL] [Abstract][Full Text] [Related]
35. [Report of cancer epidemiology in China, 2015].
Zheng RS; Sun KX; Zhang SW; Zeng HM; Zou XN; Chen R; Gu XY; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):19-28. PubMed ID: 30678413
[No Abstract] [Full Text] [Related]
36. Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019.
Zhang Y; Liu J; Han X; Jiang H; Zhang L; Hu J; Shi L; Li J
Front Public Health; 2022; 10():994619. PubMed ID: 36159285
[TBL] [Abstract][Full Text] [Related]
37. Incidence of Cancer in Shenzhen, Guangdong Province during 2001-2015: A Retrospective Population-Based Study.
Xu Z; Zhou H; Lei L; Li H; Yu W; Fu Z; Wu N; Peng J; Yin P
Int J Environ Res Public Health; 2017 Sep; 14(10):. PubMed ID: 28953262
[TBL] [Abstract][Full Text] [Related]
38. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.
Cao W; Chen HD; Yu YW; Li N; Chen WQ
Chin Med J (Engl); 2021 Mar; 134(7):783-791. PubMed ID: 33734139
[TBL] [Abstract][Full Text] [Related]
39. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea.
Yang S; Lin S; Li N; Deng Y; Wang M; Xiang D; Xiang G; Wang S; Ye X; Zheng Y; Yao J; Zhai Z; Wu Y; Hu J; Kang H; Dai Z
J Hematol Oncol; 2020 Nov; 13(1):146. PubMed ID: 33138852
[TBL] [Abstract][Full Text] [Related]
40. Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases.
Ding C; Fu X; Zhou Y; Liu X; Wu J; Huang C; Deng M; Li Y; Li L; Yang S
BMJ Open; 2019 Apr; 9(4):e025613. PubMed ID: 31015269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
